MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Chemistry World
July 18, 2012
Andrew Turley
Obesity drug approved in US US regulators have approved a new obesity treatment. Qsymia (phentermine, topiramate) tablets have been approved for overweight adults as part of a regimen that includes a low calorie diet and exercise. mark for My Articles similar articles
Health
April 2007
Joan Raymond
The "New" Diet Pills Drugs for depression, anxiety, and seizures are being used for weight loss. But do they work and are they safe? mark for My Articles similar articles
Managed Care
January 2006
Martin Sipkoff
Skeptics Abound as Demand Grows For Obesity Treatments Changes in reimbursement patterns for obesity drugs will take several years. Lifestyle changes remain the first approach. mark for My Articles similar articles
The Motley Fool
November 23, 2009
Brian Orelli
The Side Effect of Developing Obesity Drugs The FDA is fickle when it comes to weight-loss drugs. mark for My Articles similar articles
The Motley Fool
July 30, 2010
Brian Orelli
A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs. mark for My Articles similar articles
Managed Care
June 2007
Headlines On Deadline ... NCQA has published an expanded set of measures, guidelines, and technical specifications...A new strategy proposed by America's Health Insurance Plans would create an independent entity to compare the safety... etc. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2011
Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2008
Jeffrey S. Aronin
The Orphan Opportunity The Orphan Drug Act was passed 25 years ago. But the challenge of actually getting rare disease drugs and therapies to patients still remains mark for My Articles similar articles
The Motley Fool
August 25, 2009
Brian Orelli
How to Keep From Losing Your Shirt More side effects for weight-loss drugs -- maybe. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2006
Patrick Clinton
From the Editor: Undecided People are buying drugs, because companies are selling drugs. Interfere with the selling process, and people won't buy as many drugs. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2006
Musacchio & Hunkler
More Than a Game of Keep Away The Prescribing Data Restriction Program takes effect in July. The AMA explains how individual doctors can keep their prescribing habits safe from reps, and how pharma can keep using the anonymous data -- if the industry polices itself. mark for My Articles similar articles
Managed Care
September 1999
AMA, Federal Government Fret More About Online Prescribing and Pharmacy The AMA has come out with its strongest condemnation of online prescribing, recommending that action be taken against physicians who prescribe based solely on a patient's answers to an online questionnaire.... mark for My Articles similar articles
Managed Care
December 2004
Jack McCain
The Weight Debate, Continued This article presents the views of people who indulge in what many regard as health care heresy. They challenge the conventional wisdom that millions of Americans need to lose tons of weight, fast, to stave off diabetes, heart disease, cancer. mark for My Articles similar articles
American Family Physician
January 15, 2007
Pollock et al.
Appropriate Prescribing of Medications: An Eight-Step Approach These eight steps, along with ongoing self-directed learning, compose a systematic approach to prescribing that is efficient and practical for the family physician. mark for My Articles similar articles
The Motley Fool
April 5, 2005
Stephen D. Simpson
Can Obesity Fatten Your Wallet? Obesity is an increasingly serious problem, but could it also be a major opportunity for health-care companies? Investors should spend a little due diligence on the pharmaceutical side. mark for My Articles similar articles
Managed Care
February 2001
Michael Levin-Epstein
HIPAA Privacy Rules Create Uncertainty, Compliance Woes When it comes to information-sharing, just when does 'no' mean 'no'? What about conflicting statutes? We have two years to sort it out... mark for My Articles similar articles
BusinessWeek
February 27, 2006
Catherine Arnst
Weight Loss: The Spirit Is Willing -- But Pills Work Doctors may decide that weight loss is best accomplished with the new drug Acomplia. mark for My Articles similar articles
Pharmaceutical Executive
July 1, 2011
Cabacungan & Clark
New Ways to Gain New Brand Insights If you can learn to understand patient and physician behavior, you are well on your way to strengthening the position of your product. mark for My Articles similar articles
Nutrition Action Healthletter
March 2000
Michael F. Jacobson
News From CSPI As suggested by the intense interest in Syndrome X and low-carbohydrate diets, America has one of the highest rates of obesity in the world. Time will tell whether our nation chooses a lifestyle built around fitness---or gluttony and sloth. mark for My Articles similar articles
Managed Care
February 2007
MargaretAnn Cross
How Much Trouble Does Health Care Marketing Cause? Whether for drugs, imaging, surgery, or emergency services, direct-to-consumer advertising sparks lively debate. mark for My Articles similar articles
Managed Care
November 2007
La Puma & Palmer
Weight-Loss Programs Need Health Plan Support Weight-loss programs have dismal success rates. Insurers can play an active part in helping members change their thinking, and therefore change their lifestyles mark for My Articles similar articles
AskMen.com
James Fell
Qnexa Do the substantial weight-loss benefits of Qnexa more than compensate for the risks of taking it? mark for My Articles similar articles
BusinessWeek
July 2, 2007
Arlene Weintraub
Lifestyle Drug Binge The huge profits in weight-loss and other treatments makes them hard for drugmakers to resist. But safety risks abound. mark for My Articles similar articles
The Motley Fool
March 14, 2008
Brian Orelli
Weighing In on Obesity Drugs Could investing in drugmakers that produce weight-loss drugs help fatten your wallet? mark for My Articles similar articles
American Family Physician
March 15, 2003
McInnis et al.
Counseling for Physical Activity in Overweight and Obese Patients An estimated 97 million adults in the United States, or more than six out of 10 men and women, are overweight or obese. The role of physicians and other health care professionals is associated with greater efforts to help patients adopt healthy lifestyle habits related to diet and exercise. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2010
Tracking Meetings in Troubled Times Scrutiny of pharmaceutical promotion and gifts to practitioners has intensified, with more states enacting reporting requirements. What kind of impact is all this having on meetings and physician attendance? mark for My Articles similar articles
The Motley Fool
April 6, 2005
Stephen D. Simpson
Investing in Controlling Obesity While every investor must do their own due diligence, here is an outline of at least some of the major ways that investors can hope to profit from medical technology aimed at curing, or at least controlling, obesity.. mark for My Articles similar articles
Managed Care
October 2004
Tony Schueth
Formulary Standards Key To E-Prescribing Success Electronic prescribing needs standardization before it's adopted by the masses. Start with the format of formulary databases. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2006
Cindy D'Aoust
Who's Coming to Meetings? Need to attract the "right" physicians to a promotional meeting? Have to do it on a budget while following new compliance rules? Check out this new survey to see how the rest of pharma lives with a shifting promotional landscape. mark for My Articles similar articles
Managed Care
March 2007
Martin Sipkoff
Plans, PBMs, Employers Prod Docs To E-Prescribe Widespread adoption of electronic prescribing is inevitable, yet physicians still resist. Various coalitions and initiatives are trying to make adoption easier. mark for My Articles similar articles
Managed Care
February 2002
Alan M. Muney
Evidence-Based Medicine Needs To Be Promoted More Vigorously This means using a carrot-and-stick approach with physicians. Those who respect the evidence should be rewarded; others should face penalties... mark for My Articles similar articles
Managed Care
November 2006
Arthur Lazarus
Expert Opinions Create Liability for Physicians Physicians cannot rely on courts, drug companies, or HMOs to protect their freedom of speech. Their experience and knowledge form the foundation of all medical opinion. mark for My Articles similar articles
Pharmaceutical Executive
July 3, 2007
LeVine & Zucker
Marketing to Professionals: Professional Promotion Through Patient Understanding Patient-feedback programs can go a long way in helping physicians understand which drugs work. mark for My Articles similar articles
Insurance & Technology
September 16, 2005
Phil Britt
Ounce of Prevention Horizon Blue Cross Blue Shield of New Jersey is providing system physicians with the ability to prescribe medicines electronically, which should improve safety and efficiency. mark for My Articles similar articles
Managed Care
June 2001
Frank Diamond
HMO/Physician Strain Creates Invisible Costs Perhaps goodwill is too much to ask for. However, peaceful coexistence can certainly help all players reach their mutual goal -- a smooth relationship that helps to get the job done... mark for My Articles similar articles
American Family Physician
August 15, 2005
Carrie Morantz
Newsletter Latest Senate EHR Bill Combines and Replaces Previous Proposals... Agencies Collaborate to Help Patients Recover from Mental Illness... Study: Most Americans Do Not Think Obesity Risks Are Overestimated... etc. mark for My Articles similar articles
Pharmaceutical Executive
April 10, 2014
Obama Policies Reshape Pharma Marketing Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler. mark for My Articles similar articles
Managed Care
July 2007
Managed Care Outlook The future holds too few docs. mark for My Articles similar articles